Cell Culture and Bulk Antibody Production
Using class-leading technology The Antibody Company can quickly produce mg to gram quantities of monoclonal antibodies at concentrations 10-100 times that produced by common techniques
Bulk Production
The Antibody Company offers a number of methods for upscaling to generate antibodies at a larger scale, achieving mg to gram quantities.
Our technology, which uses double compartment bioreactors, for bulk antibody production is ideal for use with serum, reduced serum or serum free medium.
-
These double compartment bioreactors allow growth of cells much higher density and greatly increases secreted product concentrations, up to 100 fold.
-
These features ultimately allow for long-term, continuous culture from which a high concentration of antibody can be obtained for several weeks or months.
3rd Party Cell Culture Problem solving
TAC has significant expertise in solving culture and low production yield problems on 3rd party cell lines, resulting in optimised and efficient culture.
-
Poorly growing cells
-
Poor producers
-
Media optimisation
-
Recloning
-
Transfer to CHO/HEK
ISO9001 Complaint Cell Banking
We have onsite storage with dual liquid nitrogen repositories.
-
Cell bank mirroring between storage tanks ensuring comprehensive cover against repository failure.
-
24/7 monitoring facilities
-
Secure your critical cell lines with expert offsite storage
Interested in the history of Monoclonal Antibodies?
Read our guide on the advancement in the production of monoclonal antibodies from the 1960s up to the present day.
De-risk promising early stage technology by using The Antibody Company's integrated research and production facilities and over 20 years' experience for developing diagnostics and therapeutics. Our Virtual Lab packages can speed up the process and save significant up-front expenditure on specialist equipment and staff.
We offer our Virtual Lab expertise for assistance and partnering in grant and commercial applications.
